From today’s laparoscopic cadaver lab by the one and only Mario M. Leitao, Jr and the dedicated team of surgeons at the gynecology service. Absolutely blown away by the feedback from this course. Looking forward to the robotic one! 🤖🦾 Team Ovary, Memorial Sloan Kettering Cancer Center

Thank you IJGC for featuring our graphical abstract and article on outcomes of procedural interventions for oligoprogressive disease during tx with #immunotherapy for #gyncancers . Read more about it below 👇🏼
Ginger J. Gardner Dmitriy Zamarin MD PhD

Take a look at our new publication finding that complete gross resection of ovarian cancer at time of secondary cytoreductive surgery is associated with improved progression free survival in the era of targeted maintenance therapy. Sarah Ehmann Ginger J. Gardner

pubmed.ncbi.nlm.nih.gov/38640773/

Join us in congratulating Moe Byrne MD MSCR on winning the clinical research award at OncLive.com we are so proud of you. Vance Broach Memorial Sloan Kettering Cancer Center Nadeem R. Abu-Rustum Mario M. Leitao, Jr 👏👏👏👏👏👏

Honored to be a recipient of an ASCO Conquer Cancer, the ASCO Foundation 2024 Annual Meeting Merit Award!!! 😊Thank you for supporting trainees and research 🔬🤓. I have the best mentors Ying Liu Sara Moufarrij Kara Long Team Ovary, Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center #ovariancancerresearch

Pathbreaking Advances in Rare Ovarian Cancers by Dr. Rachel Grisham was a 💯 at ZEAL FOR TEAL! Now available On Demand on our YouTube.
Subscribe. Watch. Share! #ZealForTeal24 Team Ovary, Memorial Sloan Kettering Cancer Center GYN Cancer | #GYNCSM
WATCH full video: youtu.be/20_XhLVDECI?fe…

Don’t forget about this exciting webinar discussing the RAMP 301 trial! Happening today, April 15 at 3pm EDT. Please access through the link below. Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus

This Monday April 15 at 3pm EDT join us to learn about an exciting clinical trial opportunity for patients with recurrent LGSOC. RAMP 301 investigates the novel combination of avutometinib + defactinib. Link below! @rachelgrishamMD

edu360.igcs.org/Listing/Newly-…

Congratulations to the amazing Duaa Al-Rawi, MD PhD on presenting her incredibly innovative work at #AACR24 helping to investigate early transformations in HGSOC.

We were so fortunate to have the opportunity to listen to a fantastic talk by Dr. Jonathan Ledermann visiting us from the University College London Cancer Institute discussing the evolution and future directions of PARP inhibitors in ovarian cancer. Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus

#ARIAII a very exciting randomized controlled surgical trial of near-infrared angiography during rectosigmoid resection and anastomosis in patients with ovarian cancer is now enrolling! Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus Mario M. Leitao, Jr

Exciting new paper from Beryl Manning-Geist, MD and Jenny Mueller MD showing that integration of molecular and pathologic data can enhance selection of candidates with endometrial cancer for ovarian preservation. MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center

pubmed.ncbi.nlm.nih.gov/38508587/

Dr. Rachel Grisham in the house to Talk About Pathbreaking Advances in Rare Ovarian Cancers. So needed topic, thank you Dr. Grisham!

Important new publication from Moe Byrne MD MSCR Tiffany Sia MD and Ying Liu showing that mainstreaming increased the likelihood of genetic testing in patients with epithelial ovarian cancer. Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus

pubmed.ncbi.nlm.nih.gov/38493020/

Another great poster session at #SGOmtg with our talented fellow Mackenzie Sullivan sharing his work! Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus

Excellent presentation on the #SGOmtg main stage by superstar Beryl Manning-Geist, MD discussing her important work evaluating folate receptor positivity in low-grade serous ovarian cancer Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus

Excellent presentation on the #SGOmtg main stage by superstar Beryl Manning-Geist, MD discussing her important work evaluating folate receptor positivity in low-grade serous ovarian cancer Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus

Amazing presentation by our fellow Stephen Graves on PFS and OS in HRD ovarian cancer without a BRCA mutation and expert distillation by Ying Liu Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus

Amazing presentation today by Tiffany Sia MD at #SGO2024 with simultaneous publication with Moe Byrne MD MSCR “Mainstreaming in parallel with ovarian cancer tumor testing to improve #genetictesting sciencedirect.com/science/articl… Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus MSK Department of Medicine

Our superstar fellow and social media fellow Tiffany Sia MD presenting her work on the impact on genetic testing mainstreaming in ovarian cancer. We are so proud of you. 😍🏆🤩🤩🤩🤩🤩👏🏼👏🏼👏🏼👏🏼 #SGO2024 #gyncsm #SGOMtg IJGC IJGC Fellows Ying Liu Team Ovary, Memorial Sloan Kettering Cancer Center